Routine PDMR shareholding notification with no trading signal. Monitor upcoming quarterly earnings for fundamental developments.
Price Chart
Executive Summary
GSK filed a Form 6-K reporting routine share acquisitions by multiple PDMRs (including the CEO, CFO, and other senior executives) through the company's Share Reward Plan and dividend reinvestment on October 8-9, 2026. These are mechanical, pre-scheduled transactions tied to the company's compensation and dividend programs, not discretionary open-market buys. The filing contains no material financial data, guidance, or operational updates.
Key Facts
- CEO Luke Miels acquired 3 ordinary shares at £17.5852 via dividend reinvestment on 2026-10-08.
- CFO Julie Brown acquired 14 ordinary shares (7 partnership + 7 matching) at £17.6539 via the Share Reward Plan on 2026-10-09.
- President Europe Lynn Baxter acquired 39 ordinary shares at £17.5852 via dividend reinvestment and 14 shares at £17.6539 via the Share Reward Plan.
- President Corporate Development David Redfern acquired 80 ordinary shares at £17.5852 via dividend reinvestment, 14 shares at £17.6539 via Share Reward Plan, and 20 shares at £17.6650 via ISA dividend reinvestment.
- President US Maya Martinez-Davis acquired 10.155 American Depositary Shares at $47.02 via the Executive Supplemental Savings Plan on 2026-10-07.
- All transactions were executed on the London Stock Exchange (XLON) or New York Stock Exchange (XNYS) and were pre-scheduled under GSK's compensation/dividend plans.
- No financial results, guidance, or business updates were included in the filing.
Financial Impact
Negligible, total value of all disclosed acquisitions is approximately £2,500-£3,000 across all PDMRs, representing a de minimis fraction of GSK's market cap.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001654954-26-008889 |
| Document: 0001654954-26-008889-index-headers.html | 0001654954-26-008889 |
| Document: 0001654954-26-008889-index.html | 0001654954-26-008889 |
| Document: 0001654954-26-008889.txt | 0001654954-26-008889 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 28, 2026 today | 6-K | $49.07 | awaiting T+5 | awaiting T+5 | $48.74 (−0.67%) |
Oct 26, 2026 2d ago | 6-K | $51.10 | awaiting T+5 | awaiting T+5 | $48.74 (−4.62%) |
Oct 26, 2026 2d ago | 6-K | $51.10 | awaiting T+5 | awaiting T+5 | $48.74 (−4.62%) |
Oct 26, 2026 2d ago | 6-K | $51.10 | awaiting T+5 | awaiting T+5 | $48.74 (−4.62%) |
Oct 26, 2026 3d ago | 6-K | $51.10 | awaiting T+5 | awaiting T+5 | $48.74 (−4.62%) |
Oct 21, 2026 8d ago | 6-K | $50.02 $50.94 | ▲ +1.84% | ▲ +2.28% | $48.74 (−2.56%) |
Oct 19, 2026 9d ago | 6-K | $49.46 $51.10 | ▲ +3.32% | ▲ +3.46% | $48.74 (−1.46%) |
Oct 19, 2026 9d ago | 6-K | $49.46 $51.10 | ▲ +3.32% | ▲ +3.46% | $48.74 (−1.46%) |
Oct 15, 2026 13d ago | 6-K | $49.02 $51.21 | ▲ +4.47% | ▲ +5.48% | $48.74 (−0.57%) |
Oct 14, 2026 14d ago | 6-K | $47.87 $50.02 | ▲ +4.49% | ▲ +4.04% | $48.74 (+1.82%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers